MedTrace Logo

Controlling And Lowering Blood Pressure With the MobiusHDTM Device

NCT02804087 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2023-10-10

No results posted yet for this study

Summary

To evaluate the safety and performance of the MobiusHD system in subjects with resistant hypertension.

Conditions

Interventions

DEVICE

MobiusHD

The MobiusHD device is a self-expanding nitinol implant that is delivered intravascularly to the internal carotid sinus via the delivery catheter.

OTHER

Sham Implantation

Sham Implantation

Sponsors & Collaborators

  • Vascular Dynamics, Inc.

    lead INDUSTRY

Principal Investigators

  • Wilko Spiering, MD · UMC Utrecht

  • Jan Van der Heyden, MD · St. Antonius Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-24
Primary Completion
2021-06-30
Completion
2021-07-21
FDA Device
Yes

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02804087 on ClinicalTrials.gov